ATGEN

Dead / Abandoned — Abandoned — after inter partes decision (as of 05 Feb 2019)

What this means for you

This application is over — abandoned 05 Feb 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
86300715
Mark type
Design + words
Filed
04 Jun 2014
Published for opposition
26 May 2015
Abandoned
05 Feb 2019
Attorney of record
Margaret C. McHugh

Goods and services

  • Class 001 — Chemicals: Proteins in raw material form for scientific and medical research; Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for use by others in manufacturing pharmaceutical and veterinary preparations; proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for scientific and research purposes; diagnostic kits for clinical laboratory use, namely kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA in disease diagnosis screening, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use
  • Class 005 — Pharmaceuticals: Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones for veterinary or medical purposes: hormones; diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use
  • Class 035 — Advertising and business services: Online retail store services featuring proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; online retail store services featuring vitro diagnostic devices and antibody detection kits
  • Class 040 — Treatment of materials: Custom manufacture of proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; Custom manufacture of in vitro diagnostic devices and antibody detection kits
  • Class 042 — Scientific and technological services: medical research services; scientific research, namely, conducting clinical research trials; research and development of medicines based on protein and peptide therapeutic applications; medical diagnostic services; biological DNA cloning services; protein expression services in the field of biotechnology, namely, DNA gene cloning services, purification process development; laboratory services relating to the production of monoclonal antibodies; medical and scientific research services, namely, monoclonal antibody development, generation and screening and design related thereto

Owner

Prosecution history

  • 05 Feb 2019 — ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
  • 05 Feb 2019 — ABANDONMENT - AFTER INTER PARTES DECISION
  • 05 Feb 2019 — OPPOSITION TERMINATED NO. 999999
  • 05 Feb 2019 — OPPOSITION DISMISSED NO. 999999
  • 02 Dec 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 22 Sept 2015 — OPPOSITION INSTITUTED NO. 999999
  • 22 Jun 2015 — EXTENSION OF TIME TO OPPOSE RECEIVED
  • 26 May 2015 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 26 May 2015 — PUBLISHED FOR OPPOSITION
  • 06 May 2015 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 17 Apr 2015 — LAW OFFICE PUBLICATION REVIEW COMPLETED
  • 14 Apr 2015 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 19 Mar 2015 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 19 Mar 2015 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 12 Mar 2015 — ASSIGNED TO LIE

View this trademark record on Marksy